Ireland· IE-PA-EU/1/21/1530/001
Ontozry 25 mg film-coated tablets
A cenobamate product containing cenobamate, registered in Ireland by Angelini Pharma Italia S.P.A.. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Cenobamate is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AX25 (cenobamate), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Cenobamate · ATC N03AX25
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cenobamate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $4.11 in France to $21.72 in Switzerland — a ×5.3 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cenobamate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$21.72
- IT Italy$19.89
- CZ Czechia$4.12
- FR France$4.11
The record
At a glance
HPRA (Ireland)- Active substance
- Cenobamate
- Manufacturer
- Angelini Pharma Italia S.P.A.
- Country
- Ireland (IE)
- ATC code
- N03AX25
- ATC class
- Cenobamate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1530/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for cenobamate.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cenobamate · interactions on record
273 records
- 29 severe
- 237 moderate
- 7 minor
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cenobamate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandOntozry 12.5 mg, Tabletten und Ontozry 25 mg, FilmtablettenAngelini Pharma S.p.A., Rom, Zweigniederlassung Zug
- United StatesXcopriSK Life Science, Inc.
- BelgiumOntozry 25 mg - 12.5 mgAziende Chimiche Riunite Angelini Francesco
- NetherlandsOntozry 25mg, filmomhulde tabletAngelini Pharma S.p.A
- NorwayOntozryAngelini Pharma S.p.A.
- SwedenOntozry 25 mg + 12,5 mg Filmdragerad tablett + tablettAngelini Pharma S.p.A.
- CzechiaONTOZRYAngelini Pharma S.p.A, Rome
- FinlandOntozryAngelini Pharma S.p.A
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ontozry
- Liechtenstein · Ontozry
- Norway · Ontozry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b73b842-4f1d-4b93-9c26-ac76063e57f5 GET /v1/drugs/8b73b842-4f1d-4b93-9c26-ac76063e57f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N03AX",
"N03AX25"
],
"strength": null,
"pa_number": "EU/1/21/1530/001",
"substances": [
"Cenobamate"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/03/2021",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about cenobamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.